ANOKION.COM: Keyword Density Checker

Total words: 837 | 2-word phrases: 217 | 3-word phrases: 234 | 4-word phrases: 238

PAGE INFO

Title	Try to keep the title under 60 characters (7 characters) Anokion
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (4 characters) Home

#	Keyword	Frequency	Density
1	read more	3	1.28%
2	releases publications in	2	0.85%
3	overview press releases	2	0.85%
4	pipeline overview synced	2	0.85%
5	overview synced aceditceliac	2	0.85%
6	disease acedceliac disease	2	0.85%
7	acedceliac disease movesitmultiple	2	0.85%
8	disease movesitmultiple sclerosis	2	0.85%
9	movesitmultiple sclerosis investorsmedia	2	0.85%
10	press releases publications	2	0.85%
11	our approach pipeline	2	0.85%
12	publications in the	2	0.85%
13	in the news	2	0.85%
14	the news careers	2	0.85%
15	news careers contact	2	0.85%
16	us privacy euuk	2	0.85%
17	privacy us privacy	2	0.85%
18	use privacy us	2	0.85%
19	approach pipeline overview	2	0.85%
20	of use privacy	2	0.85%
21	overview leadership team	2	0.85%
22	for celiac disease	2	0.85%
23	scienceplatform what is	2	0.85%
24	directors scienceplatform what	2	0.85%
25	of directors scienceplatform	2	0.85%
26	read more october	2	0.85%
27	board of directors	2	0.85%
28	team board of	2	0.85%
29	leadership team board	2	0.85%
30	1b2 acedit trial	1	0.43%

#	Keyword	Frequency	Density
1	the news careers contact	2	0.84%
2	of use privacy us	2	0.84%
3	pipeline overview synced aceditceliac	2	0.84%
4	approach pipeline overview synced	2	0.84%
5	our approach pipeline overview	2	0.84%
6	privacy us privacy euuk	2	0.84%
7	disease acedceliac disease movesitmultiple	2	0.84%
8	acedceliac disease movesitmultiple sclerosis	2	0.84%
9	disease movesitmultiple sclerosis investorsmedia	2	0.84%
10	directors scienceplatform what is	2	0.84%
11	of directors scienceplatform what	2	0.84%
12	board of directors scienceplatform	2	0.84%
13	team board of directors	2	0.84%
14	leadership team board of	2	0.84%
15	overview leadership team board	2	0.84%
16	overview press releases publications	2	0.84%
17	press releases publications in	2	0.84%
18	releases publications in the	2	0.84%
19	read more october	2	0.84%
20	publications in the news	2	0.84%
21	in the news careers	2	0.84%
22	use privacy us privacy	2	0.84%
23	transforming autoimmune therapy view	1	0.42%
24	our science our programs	1	0.42%
25	view our science our	1	0.42%
26	autoimmune therapy view pipeline	1	0.42%
27	skip to content anokion	1	0.42%
28	antigens view our science	1	0.42%
29	view pipeline news may	1	0.42%
30	pipeline news may 20	1	0.42%
31	news may 20 2024	1	0.42%
32	may 20 2024 anokion	1	0.42%
33	announces new clinical data	1	0.42%
34	new clinical data from	1	0.42%
35	clinical data from the	1	0.42%
36	data from the phase	1	0.42%
37	from the phase 1b2	1	0.42%
38	the phase 1b2 acedit	1	0.42%
39	phase 1b2 acedit trial	1	0.42%
40	therapy view pipeline news	1	0.42%